ORLANDO, Fla. – The American Association for Cancer Research will hold its 102nd Annual Meeting at the Orange County Convention Center from April 2-6, 2011.
More than 18,000 people will gather to hear the latest innovations in basic, translational and clinical research. The AACR Communications Department has prepared the following press conference schedule based on the most exciting cancer research to be presented at the Annual Meeting. A full press kit with embargoed materials and teleconference information will be distributed on March 25.
Saturday, April 2:
10:00 a.m. ET “Drugs in the Pipeline: Emerging Therapies in Clinical Trials”
2:00 p.m. ET “Telomeres, Stress and Cancer Risk: Keys to Cancer Prevention”
Sunday, April 3:
1:00 p.m. ET “Cancer Discovery: AACR Launches Its Newest Journal”
3:00 p.m. ET “AACR Initiatives in Public Policy for 2011 and Beyond”
Monday, April 4:
8:30 a.m. ET “Innovative Diagnostics”
11:00 a.m. ET “Cancer Risk Factors and Genetics”
# # #
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: www.aacr.org/PressRegistration
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the worlds oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
In Orlando, April 2-6: